Abstract
Dipeptide L-threonyl-L-methionine (Thr-Met) is characterized structurally by means of a solid-state linear polarized IR- spectroscopy (IR-LD) of oriented samples as a colloidal suspension in nematic liquid crystal and quantum chemical ab initio calculations. Vibrational analysis supports the experimental data as well. The role of intermolecular hydrogen bonding on conformational behavior and spectroscopic properties of the compound, studied in solid state is determined.
Keywords: Thr-Met, IR-LD spectroscopy, ab initio calculations, solid-state
Protein & Peptide Letters
Title: Structural and IR-Spectroscopic Elucidation of Dipeptide L-Threonyl-LMethionine in Solid State
Volume: 16 Issue: 11
Author(s): A. G. Chapkanov and S. Y. Zareva
Affiliation:
Keywords: Thr-Met, IR-LD spectroscopy, ab initio calculations, solid-state
Abstract: Dipeptide L-threonyl-L-methionine (Thr-Met) is characterized structurally by means of a solid-state linear polarized IR- spectroscopy (IR-LD) of oriented samples as a colloidal suspension in nematic liquid crystal and quantum chemical ab initio calculations. Vibrational analysis supports the experimental data as well. The role of intermolecular hydrogen bonding on conformational behavior and spectroscopic properties of the compound, studied in solid state is determined.
Export Options
About this article
Cite this article as:
Chapkanov G. A. and Zareva Y. S., Structural and IR-Spectroscopic Elucidation of Dipeptide L-Threonyl-LMethionine in Solid State, Protein & Peptide Letters 2009; 16 (11) . https://dx.doi.org/10.2174/092986609789353628
DOI https://dx.doi.org/10.2174/092986609789353628 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetics and Epigenetics of Lung Cancer: Mechanisms and Future Perspectives
Current Cancer Therapy Reviews Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Recent Patents on Anti-Cancer Drug Discovery Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia
Current Cancer Drug Targets Anti-cancer Peptides from Ras-P21 and P53 Proteins
Current Pharmaceutical Design Modulation of Toll-Like Receptor 4. Insights from X-Ray Crystallography and Molecular Modeling
Current Topics in Medicinal Chemistry Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer's Disease and Other Tauopathies
Current Drug Delivery Current Pharmacological Approaches to Prevent and Treat Post- Menopausal Osteoporosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Kinetic Models for Measuring P-glycoprotein Function at the Blood-Brain Barrier with Positron Emission Tomography
Current Pharmaceutical Design The HOX Genes Network in Uro-Genital Cancers: Mechanisms and Potential Therapeutic Implications
Current Medicinal Chemistry Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued) Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy
Current Drug Targets Small Molecule Drugs and Targeted Therapy for Melanoma: Current Strategies and Future Directions
Current Medicinal Chemistry Synthesis and Antiproliferative Activity of 2-arylidene 6-(2-aryl-2-oxoethoxy)Benzofuran-3-one Derivatives
Letters in Drug Design & Discovery CYLD-Mediated Signaling and Diseases
Current Drug Targets Antidiabetic Potential of Fabaceae Family: An Overview
Current Nutrition & Food Science